Detalhe da pesquisa
1.
Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference.
Clin Infect Dis
; 76(2): 263-270, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136760
2.
The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh.
Medicina (Kaunas)
; 59(7)2023 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37512091
3.
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.
Front Immunol
; 14: 1309997, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173725
4.
Covishield vaccine induces robust immune responses in Bangladeshi adults.
IJID Reg
; 3: 211-217, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35720155
5.
Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection.
IJID Reg
; 2: 198-203, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35721426
6.
Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh.
Front Immunol
; 13: 1052374, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578502
7.
Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh.
PLoS Negl Trop Dis
; 16(1): e0010102, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34982773
8.
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
Vaccine
; 39(32): 4450-4457, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218960
9.
Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey.
Lancet Microbe
; 1(8): e336-e343, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33345203